News

January 18, 2021January 18, 2021

Mindfulness Can Alter Brain’s Perception of Pain in Cancer Survivors

News

Mindfulness can significantly improve brain health and pain perception in breast cancer survivors, according to a small Canadian study. The findings suggest that an eight-week mindfulness intervention can reduce activity ... Read more

January 14, 2021January 14, 2021

Genetic Test for Advanced Breast Cancer Launched in EU

News

Roche has launched a diagnostic genetic test to detect mutations in the PIK3CA gene in patients with advanced or metastatic breast cancer in the European Union. The cobas PIK3CA mutation test, performed ... Read more

January 11, 2021January 11, 2021

Breast Cancer Vaccine Cleared by FDA for Human Testing

News

A breast cancer vaccine can now be tested in human trials after its investigational new drug application was accepted by the U.S. Food and Drug Administration (FDA). A Phase 1 ... Read more

January 7, 2021January 7, 2021

ARX788 on FDA Fast Track for Advanced HER2-positive Breast Cancers

News

ARX788 has been given a fast track designation by the U.S. Food and Drug Administration as a monotherapy for patients with HER2-positive metastatic breast cancer previously treated with at least ... Read more

January 4, 2021January 4, 2021

Conditional Approval Urged in EU for Trastuzumab Deruxtecan

News

The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, has recommended the conditional approval of trastuzumab deruxtecan (DS-8201) for the treatment of patients with inoperable or metastatic HER2-positive breast ... Read more

December 21, 2020December 21, 2020

Margenza Approved in US for Pretreated HER2-positive Breast Cancer

News

Margenza (margetuximab-cmkb), in combination with chemotherapy, has been approved in the U.S. to treat adults with metastatic HER2-positive breast cancer who have previously received two or more anti-HER2 regimens, at ... Read more

December 17, 2020December 17, 2020

Antibody-drug Combo Shows Early Promise in Targeting Cancers, Company Says

News

BrickBio’s antibody-drug conjugate BRKB-28 showed preclinical effectiveness in eradicating breast cancer cells while leaving healthy cells unharmed, the company announced. BRKB-28 combines an antibody against a cancer protein with a ... Read more

December 14, 2020December 14, 2020

Computer Model Uses Enzyme Organization to Predict Early Breast Cancer Recurrence

News

The distinctive organization of enzymes in early breast ductal cancer can be used to correctly predict recurrences in 91% of cases, with 4% false negatives, a new study has found. ... Read more

December 10, 2020December 10, 2020

‘Unassuming’ Non-medicinal Plant Can Stop Growth of Breast Cancer Cells, Study Shows

News

Scientists have discovered that an unassuming non-medicinal plant can stop the growth of human breast cancer cells without affecting non-cancerous cells. Their research into Arabidopsis thaliana, a small annual flowering plant ... Read more

December 7, 2020December 7, 2020

Onconova Seeking FDA Approval for Phase 1 Trial of ON 123300 for Breast Cancer

News

Onconova Therapeutics is seeking the green light from the U.S. Food and Drug Administration (FDA) to begin a Phase 1 clinical trial for its small molecule ON 123300 in certain ... Read more